Drug · DIN 02293854
PLAN B
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 11, 2018; first marketed July 23, 2015.
- Drug Identification Number (DIN)
- 02293854
- Company (DIN owner)
- Foundation Consumer Healthcare, LlcPittsburgh, Pennsylvania, United States
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levonorgestrel G03AD01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVONORGESTREL | 1.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 3, 2025: NOC 35462Supplement to a New Drug Submission (SNDS) · Update to package labels
- May 9, 2018: NOC 20858New Drug Submission (NDS) · Change in product ownership
- November 22, 2016: NOC 18693Supplement to a New Drug Submission (SNDS) · Removal of class labelling warning/contraindication statement
- May 28, 2015: NOC 16937Supplement to a New Drug Submission (SNDS) · Switch from prescription to over the counter staus for 1.5 mg strength tablet
Other DINs named PLAN B
- DIN 02241674 · Cancelled Post Market